Key facts
- Apero’s last known valuation is $1.8M (Aug 2019).
- It has raised $280K; the latest was Later Stage VC in Aug 2025.
- Notable investors include Y Combinator, Soma Capital, Norwest, South Park Commons, VentureSouq — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Apero
- ·The full record, as it builds
Funding rounds
No funding rounds for Apero are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apero
Developer of a technology-enabled medical billing platform designed to automate the billing process. The company's platform combines machine learning and data science to provide automated claim submission, integrated online patient building, and a modern application programming interface, enabling users to get the benefits of a reduced denial rate.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2019
- Employees
- 19
- Website
- aperohealth.com/
- Ownership
- Privately Held (backing)
Apero doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apero shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apero in its N-PORT filings yet. We sweep new filings monthly.